Reviva Pharmaceuticals (RVPH) Q3 2025 Earnings

14AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.3
-0.24
-0.18
-0.12

Details

Expected EPS
-0.1175
Actual EPS
-0.12
Surprise EPS
-0
Surprise Percent
+2.13%

Description

Reviva Pharmaceuticals (RVPH) has reported earnings of -0.12 per share for Q3 2025.

0 Comments

Share your thoughts